| Literature DB >> 15618746 |
Hiroshi Yamazaki1, Kazuma Kiyotani, Satoshi Tsubuko, Masayuki Matsunaga, Masaki Fujieda, Tetsuya Saito, Jun Miura, Shinichi Kobayashi, Tetsuya Kamataki.
Abstract
Two novel haplotypes of CYP2D6 were found in Japanese subjects. One haplotype of the human CYP2D6 gene, newly designated as CYP2D6(*)44 allele, had both a novel single nucleotide polymorphism (SNP) of 2950G>C in intron 6 donor splice junction and a known SNP (82C<T). The newly detected mutation was as follows: SNP, 030418Tsubuko001; GENE NAME, CYP2D6; ACCESSION NUMBER, M33388; LENGTH, 25 bases; 5'-CGGATGTGCAGCG/CTGAGCCCATCTG-3'. In addition, we found the other haplotype, newly designated as CYP2D6(*)21B allele, containing -1584C>G, -1235A>G, -740C>T, -678G>A, and a gene conversion with CYP2D7 gene in intron 1 associated with CYP2D6(*)21. Both CYP2D6(*)44 and CYP2D6(*)21B alleles would cause a splicing error or a frameshift with impaired drug metabolizing function mediated by CYP2D6.Entities:
Year: 2003 PMID: 15618746 DOI: 10.2133/dmpk.18.269
Source DB: PubMed Journal: Drug Metab Pharmacokinet ISSN: 1347-4367 Impact factor: 3.614